1033 related articles for article (PubMed ID: 26202389)
1. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
3. Endovascular interventions for TASC II D femoropopliteal lesions.
Baril DT; Chaer RA; Rhee RY; Makaroun MS; Marone LK
J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
[TBL] [Abstract][Full Text] [Related]
4. One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA "STEnting Long de L'Artère fémorale superficielle" cohort).
Davaine JM; Azéma L; Guyomarch B; Chaillou P; Costargent A; Patra P; Lambert G; Gouëffic Y
Eur J Vasc Endovasc Surg; 2012 Oct; 44(4):432-41. PubMed ID: 22920949
[TBL] [Abstract][Full Text] [Related]
5. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
6. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
[TBL] [Abstract][Full Text] [Related]
7. Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment.
Rabellino M; Zander T; Baldi S; Garcia Nielsen L; Aragon-Sanchez FJ; Zerolo I; Llorens R; Maynar M
Catheter Cardiovasc Interv; 2009 Apr; 73(5):701-5. PubMed ID: 19309709
[TBL] [Abstract][Full Text] [Related]
8. Cryoplasty as endovascular treatment in the femoropopliteal region: hemodynamic results and follow-up at one year.
Gonzalo B; Solanich T; Bellmunt S; Herranz C; González E; Arnedo G; Muñoz G; Florit S; Hospedales J; Lloret MD; Vallespín J; Giménez A
Ann Vasc Surg; 2010 Jul; 24(5):680-5. PubMed ID: 20409679
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
Mohr PJ; Oyama JK; Luu JT; Stinis CT
Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.
Baril DT; Marone LK; Kim J; Go MR; Chaer RA; Rhee RY
J Vasc Surg; 2008 Sep; 48(3):627-33. PubMed ID: 18727966
[TBL] [Abstract][Full Text] [Related]
11. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
Canaud L; Alric P; Berthet JP; Marty-Ané C; Mercier G; Branchereau P
J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
[TBL] [Abstract][Full Text] [Related]
12. Plaque excision with the Silverhawk catheter: early results in patients with claudication or critical limb ischemia.
Keeling WB; Shames ML; Stone PA; Armstrong PA; Johnson BL; Back MR; Bandyk DF
J Vasc Surg; 2007 Jan; 45(1):25-31. PubMed ID: 17210379
[TBL] [Abstract][Full Text] [Related]
13. Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions.
Yin MY; Jiang ME; Huang XT; Lu M; Lu XW; Huang Y; Li WM
Chin Med J (Engl); 2013 Feb; 126(3):415-20. PubMed ID: 23422099
[TBL] [Abstract][Full Text] [Related]
14. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.
Hayes DJ; Dougherty MJ; Calligaro KD
Ann Vasc Surg; 2011 May; 25(4):559.e19-23. PubMed ID: 21549939
[TBL] [Abstract][Full Text] [Related]
15. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
16. The success of endovascular therapy for all TransAtlantic Society Consensus graded femoropopliteal lesions.
Han DK; Shah TR; Ellozy SH; Vouyouka AG; Marin ML; Faries PL
Ann Vasc Surg; 2011 Jan; 25(1):15-24. PubMed ID: 20932714
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
18. Midterm Outcomes of Endovascular Therapy for TASC II D Femoropopliteal Lesions with Critical Limb Ischemia: A Retrospective Analysis.
Liu P; Zheng LH; He XQ; Yang Y; Zhang LK; Zhang L; Zhang F
Ann Vasc Surg; 2023 Jan; 88():182-190. PubMed ID: 36007776
[TBL] [Abstract][Full Text] [Related]
19. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions.
Costanza MJ; Queral LA; Lilly MP; Finn WR
J Vasc Surg; 2004 Feb; 39(2):343-50. PubMed ID: 14743134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
